PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Authors:
- Keng-Hsueh LanKLKeng-Hsueh Lan
- Xiaoyan ZhouXZXiaoyan Zhou
- Ming TanMing Tan
- Francisco J. EstevaFEFrancisco J. Esteva
- Aysegul A. SahinASAysegul A. Sahin
- Kristine S. KlosKKKristine S. Klos
- Ping LiPLPing Li
- Brett P. MoniaBMBrett P. Monia
- Nina T. NguyenNNNina T. Nguyen
- Gabriel N. HortobagyiGHGabriel N. Hortobagyi
- Mien-Chie HungMHMien-Chie Hung
Top Cited Papers
- 1 August 2004
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 6 (2) , 117-127
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT CascadesJournal of Biological Chemistry, 2003
- Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabNature, 2003
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Tumor Suppressor PTEN Mediates Sensing of Chemoattractant GradientsCell, 2002
- Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activityOncogene, 2002
- Antibodies Stage a Comeback in Cancer TreatmentScience, 1998
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinicJournal of Clinical Immunology, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodiesCell, 1985